Phase I Study of PEG-Paclitaxel In Patients With Advanced Solid Tumors & Lymphomas
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
Studies of PEG-paclitaxel have been terminated
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started May 2001
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2001
CompletedFirst Submitted
Initial submission to the registry
August 24, 2001
CompletedFirst Posted
Study publicly available on registry
August 27, 2001
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2002
CompletedJune 24, 2005
March 1, 2004
August 24, 2001
June 23, 2005
Conditions
Keywords
Interventions
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
August 24, 2001
First Posted
August 27, 2001
Study Start
May 1, 2001
Study Completion
May 1, 2002
Last Updated
June 24, 2005
Record last verified: 2004-03